CLINICAL APPROACHES TO INTERPRETATION OF CLINICAL TRAILS RESULTS ON BETA-BLOCKERS FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE
Modern approaches to a choice of beta-blockers for treatment of patients with chronic heart failure depending on the statistical and clinical significance of randomized clinical trails results are considered. Beta-blocker «class-effect» is discussed in context of beta-blocker therapeutic tactics. Da...
Main Authors: | S. R. Giljarevskiy, I. M. Kuzmina |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2016-01-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/821 |
Similar Items
-
WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01) -
Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results
by: Yu. V. Lapina, et al.
Published: (2008-08-01) -
Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease
by: Т A Fedorova, et al.
Published: (2004-03-01) -
Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01) -
OPTIMAL USE OF BETA-BLOCKERS IN CASE OF CHRONIC HEART FAILURE
by: N. A. Shostak, et al.
Published: (2016-09-01)